PGxAI
The primary offering is an AI-driven pharmacogenetics platform that enhances drug selection and dosage through proprietary algorithms and real-world evidence. It utilizes advanced technologies, including VectorSearch and Generative AI, to deliver customized insights for various stakeholders in the healthcare sector.
- Industry: Horizontal Gen AI
- Location: Alto, California, United States
- Founded: 2023-01-01
- Total funding: 1500000
- Website: https://pgx.ai
Product & Features
- Integrates seamlessly with LIMS for streamlined data flow and automated workflows.
- Delivers rapid, actionable pharmacogenomic reports to enhance clinical decision-making.
- Adapts to client needs, supporting both routine PGx panels and advanced multi-omics profiles.
- Monitors compliance with Medicare and Medicaid guidelines to maximize reimbursement opportunities.
- Reduces adverse drug events, demonstrating value for payors and providers in value-based care.
- Offers custom solutions, including advanced panels and white-label opportunities for labs.
Similar Companies
Frequently Asked Questions
What is PGxAI?
The primary offering is an AI-driven pharmacogenetics platform that enhances drug selection and dosage through proprietary algorithms and real-world evidence. It utilizes advanced technologies, including VectorSearch and Generative AI, to deliver customized insights for various stakeholders in the…
What does PGxAI do?
Integrates seamlessly with LIMS for streamlined data flow and automated workflows. Delivers rapid, actionable pharmacogenomic reports to enhance clinical decision-making. Adapts to client needs, supporting both routine PGx panels and advanced multi-omics profiles.
What category does PGxAI fall under?
PGxAI is a legal technology company in the Horizontal Gen AI category.
Where is PGxAI based?
PGxAI is based in Alto, California, United States.
When was PGxAI founded?
PGxAI was founded in 2023.